Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-HR BAIN CAPITAL INVESTORS For: Dec 31
-
Form 13F-NT Bain Capital Integral For: Dec 31
-
Form 13F-NT BAIN CAPITAL VENTURE For: Dec 31
-
Form 13F-NT Bain Capital Partners For: Dec 31
-
Form 13F-NT Bain Capital Venture For: Dec 31
-
Form 13F-NT Bain Capital Fund X LP For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-HR BAIN CAPITAL VENTURE For: Dec 31
-
Form 13F-NT Bain Capital Integral For: Dec 31
-
Form 13F-NT Bain Capital Europe Fund For: Dec 31
-
Form 13F-NT Bain Capital Partners For: Dec 31
-
Form 13F-NT Bain Capital Partners For: Dec 31
-
Form 13F-NT BAIN CAPITAL VENTURE For: Dec 31
-
Form 13F-NT Bain Capital Venture For: Dec 31
-
Form 13F-HR Bain Capital Life Scienc For: Dec 31
-
Form SC 13G/A BRP Inc. Filed by: Bain Capital Luxembourg Investments S.a r.l.
-
Form SC 13G/A MARINUS PHARMACEUTICALS Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form 13F-HR Bain Capital Credit, LP For: Dec 31
-
Form 13F-HR Bain Capital Public Equi For: Dec 31
-
Form 13F-HR Bain Capital Public Equi For: Dec 31
-
IQVIA Announces Repurchase of Common Stock
-
Form SC 13G Bain Capital Specialty Filed by: DIMENSION CAPITAL MANAGEMENT LLC
-
Former Governor Deval Patrick withdraws from Democratic presidential race
-
E.A.T Announces Winners of $1 Million Grand Challenge to End Anaphylaxis
-
Form 13F-HR/A Bain Capital Public Equi For: Sep 30
-
Ograi BidCo AB's Proposal to the Extraordinary General Meeting in Opus Group AB (publ) on February 20, 2020
-
Hazelcast Expands Series D Funding, Raises $50 Million to Support Rapidly Increasing Demand for In-Memory Computing Platform
-
Form SC 13G Bain Capital Specialty Filed by: UBS Group AG
-
Kantar appoints ex-ITV chief Adam Crozier as chairman
-
Kantar Announce Appointment of Adam Crozier as Chairman.
-
Seed Digital Commodities Market Announces Successful Launch of Euro Trading Pairs and Extended Trading Hours
-
Seed Digital Commodities Market Announces Successful Launch of Euro Trading Pairs and Extended Trading Hours
-
Form SC 13D Arcutis Biotherapeutics, Filed by: Bain Capital Life Sciences Fund, L.P.
-
LucidLink Partners with Milestone Systems for Cloud Video Surveillance
-
LucidLink Partners with Milestone Systems for Cloud Video Surveillance
-
Awake Security Unveils Industry-First Managed Network Detection and Response Solution to Instantly Deliver Key Expertise to Customer Cybersecurity Programs
-
Herff Jones Adds Strategy And Transformation Leader Andrew Checketts To Executive Lineup
-
RSA Conference Reveals RSAC Launch Pad 2020 Participants
-
Verana Health Acquires PYA Analytics; Announces $100 Million Financing Round Led by GV
-
JenaValve Technology Closes $50 Million Financing
-
Finix Raises $35 Million To Turn Even More Software Companies Into Payments Companies
-
Form 8-K Bain Capital Specialty For: Jan 29
-
Form 3 Arcutis Biotherapeutics, For: Jan 30 Filed by: Bain Capital Life Sciences Investors, LLC
-
Italian payments group SIA taps IPO advisers; Nexi deal still an option: sources
-
Awake Security Empowers Prophix Software to Cut Through “Noisy” Alerts and Stop Real Threats on the Network
-
Griffin Capital Reaches New Record of $2.43 Billion of Equity Raise in 2019
-
Centrient Pharmaceuticals appoints Rex Clements as Chief Executive Officer after Karl Rotthier decides to step down from the role
-
Centrient Pharmaceuticals appoints Rex Clements as Chief Executive Officer after Karl Rotthier decides to step down from the role
-
Figure Names Financial Services Veteran Asiff Hirji as President

